Plenary Oral Abstract Session

Program Chair(s)

• MC

  Melissa Cushing, MD (she/her/hers)

  Clinical Laboratory Director
  Weill Cornell Medicine, New York, United States

  Disclosure(s): No financial relationships to disclose

CABP CE Eligible

Presentations:

• 9:30 AM - 11:00 AM  

  Acute Kidney Injury to Evaluate Amustaline/Glutathione Pathogen Reduced Red Cells in Cardiac Surgery: Outcomes of the ReCePI Phase III Clinical Trial
  

  Presenting Author: Edward L. Snyder, MD – Yale University
• 9:30 AM - 11:00 AM  

  ADAMTS13-Chimeric Auto-Antigen Receptor (CAAR) T cells To Target Autoreactive B cells As A Treatment For Immune-mediated Thrombotic Thrombocytopenic Purpura
  

  Presenting Author: Roman H. Khadka, PhD – University of Pennsylvania
• 9:30 AM - 11:00 AM  

  Antioxidant Responses Regulate RBC Alloimmunization
  

  Presenting Author: David R. Gibb, MD PhD (he/him/his) – Cedars-Sinai Medical Center
• 9:30 AM - 11:00 AM  

  Freeze-Dried Platelets Decrease Bleeding in Refractory Thrombocytopenic Patients with Hematological Malignancies
  

  Presenting Author: Maro Ohanian, DO – MD Anderson Cancer Center
• 9:30 AM - 11:00 AM  

  Genetic Engineering of Megakaryocytes From Blood Progenitor Cells Using mRNA Lipid Nanoparticles
  

  Presenting Author: Jerry Leung, PhD (he/him/his) – University of British Columbia
• 9:30 AM - 11:00 AM  

  Implementation of Individual Donor Assessment in the USA and Impact on Rates of Residual Infectious Disease
  

  Presenting Author: Mary Townsend, MD (she/her/hers) – Vitalant